Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee Replacement

Table 1

Baseline characteristics of the cases and the sex- and age-matched, event-free control group. *Creatinine clearance for men: (140 − age) × weight / (72 × serum creatinine, mg/dL); creatinine clearance for women: 0.85 × (140 − age) × weight / (72 × serum creatinine, mg/dL). ^†𝑛=138. ^‡𝑛=137.

	Venous thromboembolic event patients (𝑛=142)	Control patients (𝑛=140)
Males/females, n (%)	50/92 (35.2/64.8)	50/90 (35.7/64.3)
Age, years, median (range)	70 (48–85)	69 (48–86)
Height, cm, median (range)	165.1 (142–195.6)	165.0 (140–193)
Weight, kg, median (range)	86.3 (52–124.9)	84.1 (53.3–140.9)
Body mass index, kg/m^2, median (range)	30.3 (20.8–48.4)	31.0 (19.7–49.5)
Creatinine clearance, mL/min; calculated, median (range)*	92.4 (34.9–224.7)^†	88.6 (32.0–184.0)^‡